PM012

DRUG2 trials

Sponsors

VTBIO Co. LTD, Mediforum Ltd., Co.

Conditions

Alzheimer's DiseaseMild Alzheimer Disease

Phase 2

Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease

CompletedNCT01715350

VTBIO Co. LTDAlzheimer's Disease

Start: 2012-05-31End: 2015-06-30Updated: 2016-04-18

A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease

Mediforum Ltd., Co.Mild Alzheimer Disease

Start: 2020-11-27End: 2024-08-13Target: 312Updated: 2023-04-18